Widely-Used Cancer Drug Curbs Vision Loss in Eye Cancer Patients
According to a study authored by Dr. Paul Finger, injections of a widely-used cancer drug curbs vision loss due to radiation treatment of eye cancer.
“This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy. Avastin reduces abnormal blood vessel growth, stops leakage in the eye and the patients wind up seeing better. This is a first.”